Research graph
References from Beyond weight gain toward healthy cardiometabolic aging in people with HIV. Local targets link to admitted publications; unresolved targets remain external evidence.
The end of AIDS: HIV infection as a chronic disease
10.1016/s0140-6736(13)61809-7 · 2013 · External reference
HIV and aging
10.1016/j.ijid.2016.10.004 · 2016 · External reference
Characteristics, prevention, and management of cardiovascular disease in people living with HIV: a scientific statement from the American Heart Association
10.1161/cir.0000000000000695 · 2019 · External reference
Inflammation in HIV and its impact on atherosclerotic cardiovascular disease
10.1161/circresaha.124.323891 · 2024 · External reference
HIV and cardiovascular disease: we need a mechanism, and we need a plan
10.1161/jaha.116.003411 · 2016 · External reference
Weight gain and integrase inhibitors
10.1097/qco.0000000000000616 · 2020 · External reference
Metabolic disease in HIV infection
10.1016/s1473-3099(13)70271-8 · 2013 · External reference
Weight gain before and after switch from TDF to TAF in a U.S. cohort study
10.1002/jia2.25702 · 2021 · External reference
Weight gain and metabolic effects in persons with HIV who switch to ART regimens containing integrase inhibitors or tenofovir alafenamide
10.1097/qai.0000000000003101 · 2023 · External reference
Antiretrovirals and weight change: weighing the evidence
10.1093/cid/ciae191 · 2024 · External reference
TRIPOD+AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods
10.1136/bmj-2023-078378 · 2024 · External reference
HIV-Infected women gain more weight than HIV-infected men following the initiation of antiretroviral therapy
10.1089/jwh.2017.6717 · 2018 · External reference
Switch to integrase strand transfer inhibitors during the menopausal transition is associated with accelerated body composition change in women with HIV
10.1093/cid/ciae540 · 2025 · External reference
Insulin signaling in skeletal muscle of HIV-infected patients in response to endurance and strength training
10.1002/phy2.60 · 2013 · External reference
Nonalcoholic steatohepatitis and hepatic fibrosis in HIV-1-monoinfected adults with elevated aminotransferase levels on antiretroviral therapy
10.1093/cid/civ101 · 2015 · External reference
Changes in subcutaneous white adipose tissue cellular composition and molecular programs underlie glucose intolerance in persons with HIV
10.3389/fimmu.2023.1152003 · 2023 · External reference
People with HIV at the end-of-life and their next-of-kin/loved ones are willing to participate in interventional HIV cure-related research
10.1097/qad.0000000000003754 · 2024 · External reference
Semaglutide and cardiovascular outcomes in obesity without diabetes
10.1056/nejmoa2307563 · 2023 · External reference
Weight regain and cardiometabolic effects after withdrawal of semaglutide: the STEP 1 trial extension
10.1111/dom.14725 · 2022 · External reference
A 48-week, randomized controlled trial of doravirine for individuals with HIV and obesity on integrase inhibitors and tenofovir alafenamide: the Do IT Study (ACTG A5391)
10.1093/cid/ciag196 · 2026 · External reference
To switch or not to switch: are there any antiretroviral strategies to attenuate weight gain in people with HIV?
10.1007/s11904-026-00782-3 · 2026 · External reference
